Skip to main content

Advertisement

SpringerLink
Log in

Can glomerulosclerosis be reversed?

  • Viewpoint
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fogo A (2001) Progression and potential regression of glomerulosclerosis. Kidney Int 59: 804–819

    Article  CAS  PubMed  Google Scholar 

  2. Adamczak M et al. (2003) Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 14: 2833–2842

    Article  CAS  PubMed  Google Scholar 

  3. Adamczak M et al. (2004) Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. J Am Soc Nephrol 15: 3063–3072

    Article  PubMed  Google Scholar 

  4. Zoja C et al. (2002) How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 13: 2898–2908

    Article  CAS  PubMed  Google Scholar 

  5. Fujihara CK et al. (2005) An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 67: 1913–1924

    Article  CAS  PubMed  Google Scholar 

  6. Boffa JJ et al. (2003) Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 14: 1132–1144

    Article  CAS  PubMed  Google Scholar 

  7. Ma LJ et al. (2005) Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 16: 966–976

    Article  CAS  PubMed  Google Scholar 

  8. Aldigier JC et al. (2005) Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol 16: 3306–3314

    Article  CAS  PubMed  Google Scholar 

  9. Kang DH et al. (2001) Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448–1457

    Article  CAS  PubMed  Google Scholar 

  10. Liang X et al. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial outgrowth. J Am Soc Nephrol, in press

Download references

Author information

Authors and Affiliations

  1. Renal/Electron Microscopy Laboratory at Vanderbilt University Medical Center, Nashville, TN, USA

    Agnes B Fogo

Authors
  1. Agnes B Fogo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agnes B Fogo.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fogo, A. Can glomerulosclerosis be reversed?. Nat Rev Nephrol 2, 290–291 (2006). https://doi.org/10.1038/ncpneph0200

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0200

  • Springer Nature Limited

This article is cited by

Search

Navigation